Login / Signup

Spatial tumor immune microenvironment phenotypes in ovarian cancer.

Claudia MateiouLavanya LokhandeLan Hoa DiepMattis KnulstElias CarlssonSara EkKarin SundfeldtAnna Sandström Gerdtsson
Published in: NPJ precision oncology (2024)
Immunotherapy has largely failed in ovarian carcinoma (OC), likely due to that the vast tumor heterogeneity and variation in immune response have hampered clinical trial outcomes. Tumor-immune microenvironment (TIME) profiling may aid in stratification of OC tumors for guiding treatment selection. Here, we used Digital Spatial Profiling combined with image analysis to characterize regions of spatially distinct TIME phenotypes in OC to assess whether immune infiltration pattern can predict presence of immuno-oncology targets. Tumors with diffuse immune infiltration and increased tumor-immune spatial interactions had higher presence of IDO1, PD-L1, PD-1 and Tim-3, while focal immune niches had more CD163 macrophages and a preliminary worse outcome. Immune exclusion was associated with presence of Tregs and Fibronectin. High-grade serous OC showed an overall stronger immune response and presence of multiple targetable checkpoints. Low-grade serous OC was associated with diffuse infiltration and a high expression of STING, while endometrioid OC had higher presence of CTLA-4. Mucinous and clear cell OC were dominated by focal immune clusters and immune-excluded regions, with mucinous tumors displaying T-cell rich immune niches.
Keyphrases
  • low grade
  • high grade
  • immune response
  • clinical trial
  • stem cells
  • poor prognosis
  • randomized controlled trial
  • single cell
  • long non coding rna
  • inflammatory response
  • endometrial cancer
  • binding protein